|
BRPI0717638A2
(pt)
*
|
2006-10-27 |
2013-11-12 |
Genentech Inc |
Anticorpors e imunoconjugados e usos para os mesmos
|
|
TR201904484T4
(tr)
*
|
2009-11-03 |
2019-05-21 |
Hope City |
Transdüse T hücre seçimine yönelik kesik epiderimal büyüme faktörü reseptörü (EGFRt).
|
|
PH12013501201A1
(en)
*
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
EP2970985A1
(en)
*
|
2013-03-14 |
2016-01-20 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to modify cells for therapeutic objectives
|
|
WO2014165818A2
(en)
*
|
2013-04-05 |
2014-10-09 |
T Cell Therapeutics, Inc. |
Compositions and methods for preventing and treating prostate cancer
|
|
CN105873952A
(zh)
*
|
2013-10-31 |
2016-08-17 |
弗莱德哈钦森癌症研究中心 |
经修饰的造血干细胞/祖细胞和非t效应细胞及其用途
|
|
ES2819553T3
(es)
*
|
2014-12-03 |
2021-04-16 |
Juno Therapeutics Inc |
Métodos y composiciones para terapia celular adoptiva
|
|
AU2016306209B2
(en)
*
|
2015-08-07 |
2023-07-06 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Bispecific CAR T-cells for solid tumor targeting
|
|
JP2018533930A
(ja)
*
|
2015-10-02 |
2018-11-22 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
二重特異性ｔ細胞活性化抗原結合分子
|
|
IL302560B2
(en)
*
|
2015-10-13 |
2025-08-01 |
Hope City |
Chimeric antigen receptors containing a chlorotoxin domain
|
|
GB201518136D0
(en)
*
|
2015-10-14 |
2015-11-25 |
Glaxosmithkline Ip Dev Ltd |
Novel chimeric antigen receptors
|
|
EP3448427A1
(en)
*
|
2016-04-29 |
2019-03-06 |
CureVac AG |
Rna encoding an antibody
|
|
US11117936B2
(en)
*
|
2017-11-10 |
2021-09-14 |
University of Pittsburg—Of the Commonwealth System of Higher Education |
Affinity-enhanced monomeric streptavidin chimeric antigen receptor (CAR)
|
|
WO2019200347A1
(en)
*
|
2018-04-13 |
2019-10-17 |
Fred Hutchinson Cancer Research Center |
Methods for adoptive cell therapy targeting ror1
|
|
CN112166193A
(zh)
*
|
2018-05-21 |
2021-01-01 |
生物权威（英国）有限公司 |
具有经修饰的接头结构域的嵌合抗原受体及其用途
|
|
WO2019246593A2
(en)
*
|
2018-06-22 |
2019-12-26 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to target cll-1 and cd123 for the treatment of acute myeloid leukemia and related disorders
|
|
EA202190304A1
(ru)
*
|
2018-07-18 |
2022-01-21 |
Эмджен Инк. |
Химерные рецепторы к steap1 и способы их применения
|
|
SG11202107976SA
(en)
*
|
2019-01-29 |
2021-08-30 |
Juno Therapeutics Inc |
Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ror1)
|
|
CA3130671A1
(en)
*
|
2019-02-07 |
2020-08-13 |
Board Of Regents, The University Of Texas Systems |
Glucuronoxylomannan (gxm) receptor chimeric antigen receptors and use thereof
|
|
AU2020315213A1
(en)
*
|
2019-07-17 |
2022-02-03 |
National University Of Singapore |
Functional binders synthesized and secreted by immune cells
|
|
GB202208119D0
(en)
*
|
2022-06-01 |
2022-07-13 |
Univ Oslo Hf |
Anti-steap1 car
|